Adam J. Blander

Adam J. Blander


  • Brooklyn Law School (J.D., 2013)
  • McGill University (B.A., 2009)

Bar Admission

  • New York
  • New Jersey
  • U.S. District Courts for the Southern and Eastern Districts of New York

Mr. Blander's skills are demonstrated by the responsibilities he has shouldered and mastered in complex securities and consumer class actions.

Mr. Blander has represented investors and consumers in:

  • In re: PHC Shareholder Litigation, 1:11-cv-11049-PBS (D. Mass.): On behalf of stockholders of a behavioral health company arising from a stock-for-stock merger in which the company’s CEO received a multi-million dollar payment and an attractive employment package in the successor company.  Following a two-week jury trial, the Court ordered the CEO to disgorge his ill-gotten profits.  The Court of Appeals for the First Circuit thereafter affirmed the judgment and the United States Supreme Court thereafter denied the CEO's petition for certiorari.  Among other responsibilities in this case, Mr. Blander successfully argued the Class's motion for the discovery of material concerning a Securities and Exchange Commission proceeding against one of the company's directors for insider trading.  MAZ Partners LP. v. Shear, 208 F. Supp. 3d 384 (D. Mass. 2016). 
  • McLaughlin v. Wells Fargo Bank, N.A., C15-02904-WHA (N.D. Cal.): In a precedent-setting Order dated October 29, 2015, the Court ruled that the Truth in Lending Act (“TILA”) requires mortgage payoff statements to disclose property insurance proceeds creditable against the debt, observing that “[n]o decision from our court of appeals has ever addressed the issue" but that “[a]s a matter of law, the bank is wrong.”  On March 15, 2017, the Court granted final approval of a settlement providing homeowners with 88% of the maximum available monetary recovery and requiring Wells Fargo to alter its practices to comply with TILA.  Class members received over $2,500 per account.
  • In re Metrologic Inc. Shareholders Litigation, No. L-6430-06 (N.J. Super. Ct.): The plaintiffs in this action alleged breach of fiduciary duty claims on behalf of stockholders of a technology company who were cashed out in a going-private merger. In March of 2018, the Court approved a settlement with the last remaining defendants, bringing the total recovery to $21,700,000.
  • In re Hansen Medical Inc. Stockholder Litigation, No. 12316-VCMR (Del. Ch.) ($7,500,000 class settlement): On behalf of stockholders of a medical robotics company. In a much-discussed opinion dated June 18, 2018, the Delaware Court of Chancery denied the defendants’ motion to dismiss, holding, among other things, that the complaint sufficiently demonstrated that certain large stockholders who negotiated for themselves valuable “rollover” equity in the newly-merged company had acted as a “control group,” and, accordingly, could be held liable to the public stockholders, who were denied this benefit. 
  • Anwar v. Fairfield Greenwich Limited, 09-cv-118-VM (S.D.N.Y.): This action, on behalf of investors in feeder funds to the Bernard L. Madoff Investment Securities Ponzi scheme, completed in May 2016, when the Court approved a settlement with the last remaining defendant, bringing the total recovery to $235,250,000.
  • Kosinski v. GGP, Inc., 214 A.3d 944 (Del. Ch. 2019): Following trial, the Court authorized the plaintiff-stockholder to investigate the acquisition of a commercial real estate company valued at approximately $15 billion, praising the plaintiff for “doing his homework.”
  • Northstar Financial Advisors, Inc. v. Schwab Investments, 5:08-cv-04119-LHK (N.D. Cal.):  On behalf of investors in the Schwab Total Bond Market Fund, against Schwab and its trustees for causing the fund to overinvest in high-risk collateralized mortgage obligations.

Prior to joining Wolf Popper in April 2015, Mr. Blander clerked for New York State Supreme Court Justice Barbara Jaffe.  A graduate of McGill University (with great distinction) and a Brooklyn Law School Health Law and Policy Fellow (cum laude), Mr. Blander’s note “Codifying Common Law: The Self-Critical Analysis Privilege and the New Jersey Patient Safety Act,” 21 J.L. & Pol’y 577, was published in the Journal of Law and Policy in 2013.  Mr. Blander also served as a research assistant for Professor Aaron Twerski and the late Professor Richard T. Farrell and as an intern with the Health Care Bureau of the New York State Attorney General.  He won the National Law Review Winter 2011 Student Legal Writing Contest for his essay on a tax issue. 

In 2017, 2018, and 2019, Mr. Blander was named a Rising Star by Super Lawyers (New York--Metro Edition).